MoonLake Immunotherapeuti... (MLTX)

NASDAQ: MLTX · Real-Time Price · USD

42.05

1.87 (4.65%)

At close: Apr 30, 2025, 3:59 PM

41.47

-1.38%

Pre-market: May 01, 2025, 04:12 AM EDT

MoonLake Immunotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-121.24B	-44.08M	-64.51M	-53.64M	-90.84K
Depreciation & Amortization	1.38B	13.16K	12.36K	4.97K	n/a
Stock-Based Compensation	7.28B	7.11M	9.65K	10.86K	n/a
Other Working Capital	-2M	-6.22M	-44.8K	3.06M	-215.94K
Other Non-Cash Items	-4.01B	399.51K	372.49K	12.57M	-9.92K
Deferred Income Tax	n/a	n/a	n/a	1.4M	n/a
Change in Working Capital	n/a	-6.22M	-1.43M	4.48M	-215.94K
Operating Cash Flow	-116.59B	-42.78M	-55.89M	-35.18M	-316.69K
Capital Expenditures	-519.52K	-284.63K	-16.01K	-50.71K	n/a
Cash Acquisitions	n/a	n/a	32.32K	n/a	n/a
Purchase of Investments	-350.28B	-175.73M	-42.23M	n/a	-115M
Sales Maturities Of Investments	145.2B	150.83M	9.9M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-32.32K	n/a	n/a
Investing Cash Flow	-205.6B	-25.18M	-32.34M	-50.71K	-115M
Debt Repayment	n/a	n/a	-15M	15M	n/a
Common Stock Repurchased	n/a	n/a	n/a	-6.2K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	51.26B	-2.75M	134.69M	n/a	-347.38K
Financial Cash Flow	51.31B	479.7M	119.69M	43.26M	116.65M
Net Cash Flow	-270.74B	411.66M	31.47M	6.7M	1.34M
Free Cash Flow	-117.11B	-43.06M	-55.91M	-35.23M	-316.69K